PerkinElmer Files Action Against MDS, Danaher Deal | GenomeWeb

NEW YORK (GenomeWeb News) – PerkinElmer has filed an action in an Ontario court seeking to block MDS' pending sale of a joint venture between the firms to Danaher.

PerkinElmer's stake in MDS's Analytical Technologies business is due to a previously signed joint venture between PerkinElmer and MDS Sciex to develop, manufacture, and sell inductively coupled plasma mass spectrometers. MDS said that this product line represents less than 10 percent of annual revenue generated by the Analytical Technologies business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."